House , SA News Editor Thinly traded micro cap Pain Therapeutics (NASDAQ: PTIE ) craters67%premarket on increased volume in response to its announcement that it received a Complete Response Letter (CRL) from the FDA regarding its New Drug Application (NDA) seeking approval of abuse-deterrent REMOXY ER (oxycodone capsules CII). The CRL informs the company that additional actions and data are required for approval. Managementsays the actions will take about a year to complete and could cost $5M. Specifically, to support a claim against abuse by injection, it will need to repeat an injectability/syringeability study using thin films of drug, smaller volumes of solvents, additional mixed solvents and alternative extraction methods and syringe filter. To support a claim against abuse by inhalation, it will need to repeat a volatilization study using the same thickness for each drug to increase surface area. To support a claim against abuse by snorting, it will need to conduct an intranasal abuse potential study in human volunteers (the company submitted animal data in its NDA) with drug applied directly inside the human nasal cavity. In addition, the agency stated that Pain’s clinical data to support a claim against abuse by chewing is not sufficient and it will need to submit a revised proposed label to indicate that the results from the study do not support the claim. look at these guysThe filing was the company’s third attempt at approval. The company will host a conference call this morning at 9:00 am ET to discuss the situation.
For the original version including any supplementary images or video, visit http://seekingalpha.com/news/3210703-fda-rejects-pain-therapeutics-remoxy-er-marketing-application-shares-plummet-67-percent?browse around this sitesource=feed_news_all
Pain management in older people differs from than in younger people. Sean Morrison Older patients receive less analgesics than younger patients, yet had greater reductions in acute pain scores. For instance, the way in which one experiences and responds to pain is related to sociocultural characteristics, such as gender, ethnicity, and age. 66 67 An ageing adult may not respond to pain in the way that a younger person would. Jiraiya quickly blinds the Human Path then attacks with Sage Art: Goemon, which the Greta Path absorbs. The gate will either close to block inhibitory receptor the signal or open to send excitatory receptor the signal along to the next station. Seeing what the Naraka Path can do, Naruto prioritises it, distracting the Neva and Greta Paths while he hits it with another Spiralling Serial Spheres. The following techniques each require specialized equipment and personnel trained in the specific procedure being used: TENS uses tiny electrical pulses, delivered through the skin to nerve fibbers, to cause changes in muscles, such as numbness or contractions. Ibuprofen is a member of the aspirin family of analgesics, the so-called non steroidal anti-inflammatory drugs see below. Shiva locates and neutralises the chameleon, forcing Pain to summon the Greta Path and Human Path to the fray.